02:14 PM EDT, 10/07/2025 (MT Newswires) -- Trilogy Metals ( TMQ ) more than tripled amid heavy trading after the company said overnight that President Donald Trump has approved key federal permits for the Ambler Access Project in Alaska.

More than 180 million shares traded intraday compared with a daily average of about 967,000.

Envoy Medical ( COCH ) said it received approval from the US Food and Drug Administration to advance its fully implanted Acclaim cochlear implant trial to the final stage.

Shares surged 88% as intraday trading volume jumped to more than 137.6 million from a daily average of about 335,000.

Spruce Biosciences ( SPRB ) said Monday the FDA granted a breakthrough therapy designation for tralesinidase alfa in Sanfilippo syndrome.

Shares extended gains, soaring 55% with intraday trading volume at over 1.8 million compared with a daily average of about 390,000. Shares closed at $130.40 on Monday, up from $8.82 on Friday last week.

Price: 7.10, Change: +5.01, Percent Change: +239.67